Global Expansion Zambon operates across Europe, America and Asia with manufacturing units in Italy, Switzerland, France, China and Brazil and a commercial reach in 87 countries, presenting multiple regional entry points for strategic partnerships, distribution deals, and localized product registration opportunities.

Pipeline Diversification The group is building a global pipeline targeting serious diseases such as Parkinson’s, Cystic Fibrosis, BOS and NCFB, complemented by ZBiotech and Zcube ventures that seek acquisitions, licensing and development deals with innovative molecules and startups.

Open Accelerator Zcube’s Open Accelerator program emphasizes femtech and broader health venture collaboration, offering potential co-development, investment, and go-to-market partnerships with startups in high-growth segments relevant to patient care and diagnostics.

Strategic Partnerships Recent partnerships and launches, including IV Fluimucil formulation and Amneal collaboration for Parkinson’s treatment, indicate opportunistic co-development, licensing or distribution arrangements that can be leveraged for new therapeutic adjacencies and faster market access.

Supply Chain Modernization Adoption of Kinaxis for supply chain orchestration signals a focus on end-to-end visibility and resilience, suggesting sales angles around digital tools, integration, and optimization solutions for global manufacturing and cold-chain or complex biologics supply contexts.